Crizotinib: A comprehensive review
Anaplastic lymphoma kinase (ALK) gene rearrangements are present in a small subset of non-small-cell lung cancers. ALK-positivity confers sensitivity to small-molecule ALK kinase inhibitors, such as crizotinib. The integration of crizotinib into standard treatment practice in NSCLC will rest on the...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2013-01-01
|
| Serija: | South Asian Journal of Cancer |
| Teme: | |
| Online pristup: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=2;spage=91;epage=97;aulast=Sahu |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
